Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study will consist of two phases and be aimed at assessing the safety and tolerability of the new genetically attenuated GA2 malaria parasite (Phase 1) and its preliminary protective efficacy against controlled human malaria infection (Phase 2) in healthy Dutch volunteers.
Epistemonikos ID: 0b6bf6bb88d161f769537e564d690290652c0941
First added on: May 07, 2024